Tara Symonds CSO and Stacie Hudgens CEO present on establishing the reliability of the 5 Domain NPCSS ClinRO

COSStacie Hudgens

COS’s Tara Symonds CSO and Stacie Hudgens CEO assisted with establishing the reliability of the 5 Domain NPCSS ClinRO: ‘A Study to assess the Inter and Intra-rater Reliability of the 5 Domain NPCCSS’ NPCCSS Marc Patterson, Christine I Dali, Tara Symonds, Christina Guldberg, Stacie Hudgens, Eugen Mengel. The poster is being presented at ‘Society for the Study of Inborn Errors …

Stacie Hudgens, CEO of Clinical Outcomes Solutions, on the Effects of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir Regimen on Health‐related Quality of Life for Patients with Hepatitis C

COSStacie Hudgens

Stacie Hudgens, Chief Executive Officer, Strategic Lead Regulatory and Access, at COS, has an article published in Liver International: ‘Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health-related quality of life for patients with hepatitis C’ To view this article, please click here. To find out more about Stacie Hudgens, please click here.

Clinical Outcomes Solutions CEO Publishes Article on Understanding Health-related Quality of Life in an Ovarian Maintenance Clinical Trial

COSStacie Hudgens

Stacie Hudgens MSc, Chief Executive Officer, Strategic Lead Regulatory and Access, has a manuscript published in The Lancet this month, entitled ‘Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial’. This is a paper focused on understanding health-related quality of life in an ovarian maintenance …